Yanrong Huang
Beijing, 100029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Anti-Malignancy and Anti-Inflammation Properties of Emodin, an Essential Constituent in Popular Laxative Botanicals.
Journal: The American journal of Chinese medicine
Published: July 14, 2026
Tangerine Peel-Based Herbal Formula Ameliorates Metabolic Syndrome via Gut Microbiota-Mediated Bile Acid Remodeling and TGR5 Activation.
Journal: The American journal of Chinese medicine
Published: November 20, 2025
Global burden of MASLD-IBD comorbidity from 1990 to 2021 and trend prediction to 2050.
Journal: International journal of surgery (London, England)
Published: June 20, 2025
Gut microbiota drives the metabolic dysregulation in obesity-prone individuals by impairing GDCA-mediated activation of brown adipose thermogenesis and ileal GLP-1 secretion.
Journal: Acta pharmaceutica Sinica. B
Published: June 06, 2025
A meta-analysis of biologic therapies on risk of new or recurrent cancer in patients with rheumatoid arthritis and a prior malignancy.
Journal: Rheumatology (Oxford, England)
Published: December 23, 2020
Effect of tofacitinib on cardiovascular events and all-cause mortality in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials.
Journal: Therapeutic advances in musculoskeletal disease
Published: August 24, 2019
A meta-analysis of biologic therapies on risk of new or recurrent cancer in patients with rheumatoid arthritis and a prior malignancy.
Journal: Rheumatology (Oxford, England)
Published: July 11, 2019
Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis.
Journal: Arthritis research & therapy
Published: February 10, 2019
Efficacy and safety of secukinumab in active rheumatoid arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis of phase III randomized controlled trials.
Journal: Clinical rheumatology
Published: January 16, 2019
Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials.
Journal: Annals of the rheumatic diseases
Published: November 29, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026